10 new technologies tackling urgent challenges from autoimmune disease to cancer win funding from Blavatnik Biomedical Accelerator.

Five companies started with discoveries in Harvard labs and, with various forms of support, developed impactful solutions that are enhancing our quality of life.

Axoft, a startup launched with technology developed in Harvard labs, is transforming care for traumatic brain injuries with its soft, biocompatible neural probe that can quickly measure recovery and consciousness within a few minutes.

New research out of Harvard Medical School suggests that lithium deficiency may be a key driver of Alzheimer’s disease and a promising target for early diagnosis and treatment. Harvard’s Office of Technology Development has protected the innovations related to this research and is actively seeking industry partners for commercialization to advance these discoveries.